Table 2.
Odds ratios and 95% confidence intervals for risk of COVID-19 in cancer patients.
| Variable | COVID-19 Positive n (%) |
COVID-19 Negative n (%) |
OR * | 95% CI |
|---|---|---|---|---|
| Sex | ||||
| Female | 78 (41) | 1105 (56) | 1.00 | Ref. |
| Male | 112 (59) | 857 (44) | 1.85 | (1.37–2.51) |
| Age | ||||
| ≤60 | 66 (35) | 799 (41) | 1.00 | Ref. |
| >60 | 124 (65) | 1163 (59) | 1.29 | (0.94–1.76) |
| SES | ||||
| Low | 157 (83) | 1691 (86) | 1.00 | Ref. |
| Middle/High | 19 (0) | 167 (9) | 1.58 | (0.94–2.66) |
| Ethnicity | ||||
| White | 98 (52) | 1021 (52) | 1.00 | Ref. |
| Black | 42 (22) | 227 (12) | 1.93 | (1.31–2.84) |
| Asian | 7 (4) | 55 (3) | 1.33 | (0.59–2.99) |
| Other | 6 (3) | 62 (3) | 1.01 | (0.43–2.39) |
| Smoking History | ||||
| Never | 66 (35) | 497 (25) | 1.00 | Ref. |
| Ever | 67 (35) | 571 (29) | 0.91 | (0.61–1.37) |
| Cancer Type | ||||
| Solid | 157 (83) | 1778 (91) | 1.00 | Ref. |
| Haematological | 33 (17) | 162 (8) | 2.29 | (1.45–3.62) |
| Tumour Stage | ||||
| I-III | 43 (23) | 1103 (56) | 1.00 | Ref. |
| IV | 17 (9) | 302 (15) | 1.44 | (0.81–2.57) |
| Treatment Paradigm | ||||
| No active treatment | 18 (0) | 78 (4) | 1.00 | Ref. |
| Radical/Curative | 71 (37) | 853 (43) | 0.37 | (0.20–0.66) |
| Palliative | 78 (41) | 892 (45) | 0.39 | (0.22–0.70) |
| Time since cancer diagnosis | ||||
| <1 year | 96 (51) | 878 (45) | 1.00 | Ref. |
| 1–2 years | 23 (12) | 317 (16) | 0.70 | (0.42–1.16) |
| 2–5 years | 29 (15) | 370 (19) | 0.73 | (0.45–1.18) |
| ≥5 years | 36 (19) | 287 (15) | 1.11 | (0.70–1.76) |
* Adjusted models according to DAG in Appendix A.